Home Latest Articles Summary ARK Invest's Q1 2026 13F portfolio value declined to ~$12.86B with 182 holdings, reflecting continued focus on disruptive innovation across technology and biotech. Tesla, Advanced Micro Devices, CRISPR Therapeutics, Shopify, and Palantir comprise ~24% of assets, with TSLA remaining the largest position despite recent trimming. Stake increases in AMD, CRSP, TEM, CRCL, HOOD, RBLX, AMZN, BLSH, GOOGL, and CRWV, signaling conviction in AI, genomics, and fintech themes. Reductions in TSLA, PLTR, COIN, TER, ROKU, META, and DKNG, reflecting profit-taking and portfolio rebalancing amid market volatility. SusanneB/E+ via Getty Images This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest 's 13F portfolio on a quarterly basis.…